Today: 7 February 2026
Subscribe
Browse Category

Financial Outlook News 30 December 2025 - 6 February 2026

Molina Healthcare stock dives 27% after 2026 profit outlook reset; Medicare Advantage exit looms

Molina Healthcare stock dives 27% after 2026 profit outlook reset; Medicare Advantage exit looms

Molina Healthcare shares plunged 27% to $129.77 after the company forecast 2026 adjusted EPS of at least $5.00, far below the $13.76 analyst consensus. Management cited higher medical costs and a sharp pullback in ACA Marketplace membership. The company posted a Q4 adjusted loss of $2.75 per share and plans to exit its Medicare Advantage Part D business in 2027.
6 February 2026
····
Pfizer stock price edges higher as Wall Street sizes up obesity-shot data and 2026 outlook

Pfizer stock price edges higher as Wall Street sizes up obesity-shot data and 2026 outlook

Pfizer shares rose 0.8% to $27.01 by early afternoon after the company reported up to 12.3% placebo-adjusted weight loss in a Phase 2b trial of its experimental obesity drug. Investors remain cautious amid concerns over patient dropout rates and side effects. Pfizer reaffirmed its 2026 forecast, projecting $59.5–$62.5 billion in revenue and $2.80–$3.00 adjusted earnings per share.
5 February 2026
····
Pfizer (PFE) stock price slips before the bell after obesity-drug update, 2026 outlook

Pfizer (PFE) stock price slips before the bell after obesity-drug update, 2026 outlook

Pfizer shares fell 3.4% to $25.77 in Wednesday’s premarket after Novo Nordisk warned of lower 2026 sales and price pressure in obesity drugs. Pfizer’s GLP-1 trial met its main goal, showing up to 12.3% mean weight loss at 28 weeks, but safety questions remain. The company reaffirmed 2026 guidance and reported $17.6 billion in Q4 revenue. Investors await more VESPER-3 data at the June 6 ADA meeting.
4 February 2026
····
Pfizer stock drops on obesity-drug data and 2026 outlook — what investors watch next

Pfizer stock drops on obesity-drug data and 2026 outlook — what investors watch next

Pfizer shares fell 3.4% to $25.76 early Tuesday after quarterly results and new Phase 2b obesity drug data. The company reported adjusted Q4 earnings of 66 cents per share on $17.56 billion revenue, both above analyst estimates. Pfizer reaffirmed its 2026 outlook and does not plan share buybacks this year. COVID-19 product sales continued to decline sharply.
3 February 2026
····
American Express stock price slides after earnings as investors weigh 2026 outlook and costs

American Express stock price slides after earnings as investors weigh 2026 outlook and costs

American Express shares fell 2.2% to $350.61 Friday after a quarterly report showed higher expenses despite strong card spending. The company posted $3.53 per share in earnings and $18.98 billion in revenue for the December quarter, with billed business up 9% to $445.1 billion. AmEx plans to raise its dividend 16% to 95 cents and projects 2026 EPS between $17.30 and $17.90.
30 January 2026
··
Trane Technologies stock price jumps 7% after earnings, record backlog puts 2026 outlook in focus

Trane Technologies stock price jumps 7% after earnings, record backlog puts 2026 outlook in focus

Trane Technologies shares rose 7.4% to $423.37 after Q4 adjusted EPS of $2.86 and revenue of $5.15 billion topped estimates. The company ended 2025 with a record $7.8 billion backlog, up 15% from a year earlier. Bookings jumped 22% in the quarter. Trane forecasts 2026 adjusted EPS between $14.65 and $14.85.
29 January 2026
·····
Brookdale Senior Living stock jumps on early 2025 results and fresh 2026 outlook ahead of Investor Day

Brookdale Senior Living stock jumps on early 2025 results and fresh 2026 outlook ahead of Investor Day

Brookdale Senior Living shares surged nearly 11% Thursday after releasing preliminary 2025 results and its first full-year 2026 forecast. The company projects 2026 adjusted EBITDA of $502 million to $516 million and expects RevPAR growth of 8% to 9%. Brookdale reported a 2025 net loss of about $263 million, including $71 million in non-cash impairment charges. Wall Street analysts raised price targets ahead of Investor Day.
29 January 2026
····
Texas Instruments stock is flat today — what TXN investors are watching after the outlook surprise

Texas Instruments stock is flat today — what TXN investors are watching after the outlook surprise

Texas Instruments shares rose 0.1% to $216.46 after forecasting first-quarter revenue of $4.32–$4.68 billion and EPS of $1.22–$1.48. Data-center revenue jumped 70% year-over-year, now 9% of total sales. TI will report data-center sales separately going forward. The company’s next capital management webcast is set for Feb. 24.
29 January 2026
·····
Elevance Health ELV stock price jumps 6% after earnings, but 2026 outlook points to revenue dip

Elevance Health ELV stock price jumps 6% after earnings, but 2026 outlook points to revenue dip

Elevance Health shares jumped 6% to $343.14 Wednesday after the company set a 2026 profit floor despite warning of lower revenue. The move followed a $80 billion sector selloff triggered by new Medicare payment proposals. Elevance projected 2026 adjusted earnings of at least $25.50 per share and year-end enrollment up to 43.875 million. Fourth-quarter operating revenue reached $49.3 billion.
28 January 2026
·····
Hecla Mining stock slides as Casa Berardi sale and 2026 outlook sink in

Hecla Mining stock slides as Casa Berardi sale and 2026 outlook sink in

Hecla Mining shares fell 6.8% to $27.93 Tuesday after announcing the $593 million sale of its Casa Berardi gold mine to Orezone Gold. The deal includes $160 million in cash and the rest in shares and contingent payments, with closing expected in Q1 2026. Hecla also released 2026 guidance, projecting silver output of 15.1–16.5 million ounces and a capital budget up to $279 million.
27 January 2026
······
AbbVie stock edges up today as Linzess partner Ironwood cuts list price, lifts 2026 outlook

AbbVie stock edges up today as Linzess partner Ironwood cuts list price, lifts 2026 outlook

NEW YORK, Jan 2, 2026, 14:08 ET — Regular session AbbVie shares ticked higher on Friday after Ironwood Pharmaceuticals, its partner on constipation drug Linzess, raised its 2026 outlook and said it lowered the medicine’s list price at the start of the year. The update matters because Linzess is co-developed and co-commercialized with AbbVie in the U.S., and changes in pricing can shift how much revenue is left after rebates and discounts. It also lands as investors reopen the books for 2026 with drug pricing back on the agenda and macro data next week expected to reset interest-rate bets, a
2 January 2026
·····
Pfizer stock today: PFE edges up after TD Cowen sticks with Hold as investors size up 2026 outlook

Pfizer stock today: PFE edges up after TD Cowen sticks with Hold as investors size up 2026 outlook

NEW YORK, December 30, 2025, 13:50 ET — Regular session Pfizer Inc (NYSE:PFE) shares were up about 0.1% at $25.03 in afternoon trading on Tuesday, after moving between $24.92 and $25.10. TD Cowen reiterated its Hold rating and kept a $30 price target, pointing to negative trends in its model through 2030 despite the stock’s dividend yield near 7%. Investing.com The call lands as investors weigh Pfizer’s latest 2026 targets after the drugmaker projected revenue of $59.5 billion to $62.5 billion next year and adjusted earnings of $2.80 to $3.00 a share. “Adjusted” earnings strip out certain items the company
30 December 2025
·····
1 2 3 … 12

Stock Market Today

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

7 February 2026
Seagate shares rose 5.9% to $429.32 Friday after Citigroup raised its price target to $480 and reiterated a buy rating. The gain ended a two-day slide but left the stock 6.6% below its Feb. 3 high. CEO Dave Mosley sold 20,000 shares on Feb. 2 under a pre-arranged plan, SEC filings show. U.S. jobs and inflation data next week are seen as key tests for tech stocks.
Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

7 February 2026
Cummins shares jumped 6.8% to $577.73 Friday, recovering from a nearly 9% post-earnings drop the day before. The company reported Q4 revenue up 1% to $8.54 billion, took a $218 million charge tied to its hydrogen business, and guided for 2026 EBITDA of 17–18% of sales. Demand for data center generators offset weakness in North American truck markets. Analyst reaction was mixed; Truist raised its price target.
Corning stock hits first record close since 2000 as jobs, CPI data loom

Corning stock hits first record close since 2000 as jobs, CPI data loom

7 February 2026
Corning shares surged 8.3% to $122.16 Friday, their highest close since the dot-com era, after Meta agreed to buy up to $6 billion in fiber-optic cables. The stock is up 40% since late 2025, fueled by strong first-quarter guidance and AI data-center demand. Insiders sold shares following the rally, SEC filings show. Investors await next week’s U.S. jobs and inflation data for rate signals.
Go toTop